Solgen Capital Partners

Description

Solgen Capital is a sector focused private credit fund investing in lower middle-market healthcare companies. We partner with established healthcare businesses to deliver tailored financing solutions and strategic guidance to support their business needs and facilitate accelerated growth. Solgen provides tailored private debt and growth equity capital to healthcare businesses seeking to scale through organic growth and acquisition. Our team and strategic advisors collaborate closely with portfolio companies, management teams and stakeholders to be additive in helping them transform and grow their businesses. The Solgen team brings deep experience in healthcare finance, building businesses and managing investment firms. Led by a strong belief in partnership, Solgen provides value beyond capital—the Solgen team and its broader ecosystem add value through active engagement with portfolio companies. We offer: • Flexible debt and equity capital • Industry knowledge and relationships • Business building experience • Transparent & collaborative investment process • Robust diligence with decisive outcomes • Ownership mindset and equity commitment • Deep industry relationships • Team augmented with network of industry experts Where We Invest: • EBITDA typically between $2 —$30 million • Track record of profitability with stable cash flows • Capable and experienced management team with deep operational experience • Leading and secure market position in a stable and defensible subsector within healthcare • Products or services with proven market acceptance and low risk of technological obsolescence • High quality shareholders Investment Structures: • Investment size: $10-$100 million • Investment structure and covenant packages tailored to specific transactions • Securities: – Senior debt – Unitranche debt – Subordinated debt – Preferred and common equity • Ability to significantly increase transaction size with LP co-investors

AI Sector Summary

Solgen Capital is a sector-focused fund providing private credit and growth equity to lower middle-market healthcare companies with EBITDA between $2M and $30M. They specialize in tailored financing solutions for established healthcare businesses with proven market acceptance and stable cash flows.

Financials